Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis
NCT06587191
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Primary Hemophagocytic Lymphohistiocytosis
Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology